
Optinose’s XHANCE Shows Significant Promise in Chronic Sinusitis Treatment: A Breakthrough Revealed in ReOpen Clinical Trials
YARDLEY, PA — Optinose (NASDAQ: OPTN), a Pennsylvania-based pharmaceutical company, has announced the publication of results from its ReOpen1 and ReOpen2 clinical trials. The findings, published in the reputable Journal …
Optinose’s XHANCE Shows Significant Promise in Chronic Sinusitis Treatment: A Breakthrough Revealed in ReOpen Clinical Trials Read More